Abstract
Catatonic states occur in the context of a wide variety of both psychiatric and medical conditions. Since 1992 benzodiazepines represent a first-line treatment in catatonia, because they offer several advantages: a wide margin of safety, a rapid response, and they are easily administered. Other treatments include atypical antipsychotics, antiglutamatergic drugs, lithium. Lorazepam and other GABA-A promoters (benzodiazepines, zolpidem) increase GABA activity as their mechanism of action.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
